Discovery of pathway biomarkers from coupled proteomics and systems biology methods

BMC Genomics

Volumn 11, Issue SUPPL. 2, 2010, Pages

  Zhang, Fan ^a,c   Chen, Jake Y ^a,b,c  

^a Indiana University   (United States)

^b Indiana University Purdue University Indianapolis   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PEPTIDE DERIVATIVE; PLASMA PROTEIN; PROTEIN DERIVATIVE; TUMOR MARKER; PROTEOME;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER CELL; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LIQUID CHROMATOGRAPHY; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; SYSTEMS BIOLOGY METHOD; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; BREAST TUMOR; GENETICS; METHODOLOGY; SYSTEMS BIOLOGY; VALIDATION STUDY;

BLOOD PROTEINS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; PROTEOME; PROTEOMICS; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 78149308066     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-S2-S12     Document Type: Article

References (36)

1. Brooks M. Breast cancer screening and biomarkers. Methods Mol Biol 2009, 472:307-321.
2. Carlsson J, Nordgren H, Sjostrom J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. British journal of cancer 2004, 90(12):2344-2348. 2409528, 15150568.
3. Malkas LH, Herbert BS, Abdel-Aziz W, Dobrolecki LE, Liu Y, Agarwal B, Hoelz D, Badve S, Schnaper L, Arnold RJ, et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(51):19472-19477. 1697829, 17159154.
4. Culleton J, O'Brien N, Ryan BM, Hill AD, McDermott E, O'Higgins N, Duffy MJ. Lipophilin B: A gene preferentially expressed in breast tissue and upregulated in breast cancer. International journal of cancer 2007, 120(5):1087-1092.
5. Colombo M, Giarola M, Mariani L, Ripamonti CB, De Benedetti V, Sardella M, Losa M, Manoukian S, Peissel B, Pierotti MA, et al. Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases. Mod Pathol 2008, 21(10):1262-1270.
6. Lewis-Wambi JS, Cunliffe HE, Kim HR, Willis AL, Jordan VC. Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells. Eur J Cancer 2008, 44(12):1770-1779. 2778047, 18614350.
7. Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF. Osteopontin-c is a selective marker of breast cancer. International journal of cancer 2008, 122(4):889-897.
8. Rao PN, Levine E, Myers MO, Prakash V, Watson J, Stolier A, Kopicko JJ, Kissinger P, Raj SG, Raj MH. Elevation of serum riboflavin carrier protein in breast cancer. Cancer Epidemiol Biomarkers Prev 1999, 8(11):985-990.
9. Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol 2008, 61(3):327-332.
10. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L, Poyser HR, Redpath N, Griffiths M, Steers G, et al. Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer. J Biol Chem 2003, 278(8):6482-6489.
11. Bullinger D, Neubauer H, Fehm T, Laufer S, Gleiter CH, Kammerer B. Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS couplin. BMC Biochem 2007, 8:25. 2219991, 18047657.
12. Kulasingam V, Diamandis EP. Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets. Mol Cell Proteomics 2007, 6(11):1997-2011.
13. Mbeunkui F, Metge BJ, Shevde LA, Pannell LK. Identification of Differentially Secreted Biomarkers Using LC-MS/MS in Isogenic Cell Lines Representing a Progression of Breast Cancer. J Proteome Res 2007, 6(8):2993-3002. 2584611, 17608509.
14. Xiang R, Shi Y, Dillon DA, Negin B, Horvath C, Wilkins JA. 2D LC/MS Analysis of Membrane Proteins from Breast Cancer Cell Lines MCF7 and BT474. J Proteome Res 2004, 3(6):1278-1283.
15. Naylor S, Chen JY. Unraveling human complexity and disease with systems biology and personalized medicine. Personalized Medicine 2010, 7(3).
16. Burdall S, Hanby A, Lansdown M, Speirs V. Breast cancer cell lines: friend or foe?. Breast Cancer Res 2003, 5(2):89-95. 154155, 12631387.
17. Simpson RJ, Bernhard OK, Greening DW, Moritz RL. Proteomics-driven cancer biomarker discovery: looking to the future. Curr Opin Chem Biol 2008, 12(1):72-77.
18. Johann DJ, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, et al. Clinical proteomics and biomarker discovery. Ann N Y Acad Sci 2004, 1022:295-305.
19. Saha S, Harrison SH, Shen C, Tang H, Radivojac P, Arnold RJ, Zhang X, Chen JY. HIP2: An online database of human plasma proteins from healthy individuals. BMC Med Genomics 2008, 1:12. 2396660, 18439290.
20. Saha S, Harrison SH, Chen JY. Dissecting the human plasma proteome and inflammatory response biomarkers. Proteomics 2009, 9(2):470-484.
21. Huan T, Sivachenko A, Harrison S, Chen JY. ProteoLens: a Visual Analytic Tool for Multi-scale Database-driven Biological Network Data Mining. BMC Bioinformatics 2008, 9:S5. 2537576, 18793469.
22. Chen JY, Shen C, Sivachenko A. Mining Alzheimer Disease Relevant Proteins from Integrated Protein Interactome Data. Pacific Symposium on Biocomputing '06. 2006, 11:367-378. Maui, HI.
23. Chen JY, Yan Z, Shen C, Fitzpatrick DP, Wang M. A systems biology approach to the study of cisplatin drug resistance in ovarian cancers. Journal of bioinformatics and computational biology 2007, 5(2a):383-405.
24. Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER. Proteomic Analysis to Identify Breast Cancer Biomarkers in Nipple Aspirate Fluid. Clin Cancer Res 2004, 10(22):7500-7510.
25. Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, Bornmann W, Bromberg JF. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res 2007, 9(3):R32. 1929096, 17531096.
26. Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, Lu J. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol Cancer Ther 2008, 7(9):2681-2691.
27. Song H, Jin X, Lin J. Stat3 upregulates MEK5 expression in human breast cancer cells. Oncogene 2004, 23(50):8301-8309.
28. Gemmill JA, Stratton P, Cleary SD, Ballweg ML, Sinaii N. Cancers, infections, and endocrine diseases in women with endometriosis. Fertil Steril 2009, 2946463, 19945097.
29. Maia AT, Spiteri I, Lee AJ, O'Reilly M, Jones L, Caldas C, Ponder BA. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. Breast Cancer Res 2009, 11(6):R88. 2815552, 20003265.
30. Sawyer C, Sturge J, Bennett DC, O'Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res 2003, 63(7):1667-1675.
31. Wendt MK, Schiemann WP. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res 2009, 11(5):R68. 2790843, 19740433.
32. Nielsen NR, Gronbaek M. Stress and breast cancer: a systematic update on the current knowledge. Nat Clin Pract Oncol 2006, 3(11):612-620.
33. Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE. Comprehensive label-free method for the relative quantification of proteins from biological samples. Journal of proteome research 2005, 4(4):1442-1450.
34. Mehta CR, Patel NR, Tsiatis AA. Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 1984, 40(3):819-825.
35. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36(Database issue):D480-484. 2238879, 18077471.
36. Chowbina SR, Wu X, Zhang F, Li PM, Pandey R, Kasamsetty HN, Chen JY. HPD: an online integrated human pathway database enabling systems biology studies. BMC Bioinformatics 2009, 10(Suppl 11):S5.